Pharming Group N.V.

Pharming Group N.V.

Quarterly Financials

Values in thousands2026-09-302026-06-302026-03-312025-12-31
Revenue
$117,478
$90,213
$72,447
$106,500
Gross Profit
99,322
75,668
65,803
85,400
EBITDA
30,443
8,753
1,058
9,406
EBIT
27,671
5,715
-2,058
6,200
Net Income
22,376
1,638
-5,213
5,300
Net Change In Cash
117,478
90,213
72,447
106,500
Free Cash Flow
32,267
-12,765
1,714
10,438
Cash
189,560
158,281
53,104
146,021
Basic Shares
74,666
70,140
70,140
75,766

Annual Financials

Values in thousands2025-12-312024-12-312023-12-312022-12-31
Revenue
$376,134
$297,200
$245,316
$205,622
Gross Profit
330,634
261,801
220,104
188,060
EBITDA
34,782
16,315
9,877
33,533
EBIT
23,566
245
-6,048
20,345
Net Income
2,851
-11,841
-10,548
13,674
Net Change In Cash
376,134
297,200
245,316
205,622
Free Cash Flow
53,953
-2,591
-18,766
20,481
Cash
146,021
56,893
61,741
207,342
Basic Shares
71,317
68,918
65,702
84,284

Earnings Calls

QuarterEPS
2026-09-30
$0.30
2026-06-30
$0.02
2026-03-31
-$0.07
2025-12-31
$0.07